The 2024 Complete Guide to 21 CFR Part 11

The 2024 Guide to 21 CFR Part 11 simplifies compliance for FDA-regulated industries by detailing essential standards for electronic records and signatures. Essential for pharmaceuticals, biotechnology, and medical devices, it clarifies the regulation’s scope and provides strategies for strong compliance.

• Scope and Application: Unpack 21 CFR Part 11’s relevance in FDA-regulated areas, showing its effect on your digital records and signatures.
• Trustworthy Records Criteria: Learn how to establish electronic records and signatures that adhere to regulatory standards.
• Tackling Compliance Challenges: Tackle typical compliance obstacles, including integrating technology and updating legacy systems.
• Implementation Strategies: Learn key compliance steps, focusing on risk management, training, and technical approaches.

Equip your team with key insights to confidently handle 21 CFR Part 11 compliance. Download the guide for a direct route to compliance and excellence in digital record-keeping.